Related Experiment Video
Updated: Aug 9, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
SUMO in cancer--wrestlers wanted
Dania Alarcon-Vargas1, Ze'ev Ronai
1The Ruttenberg Cancer Center; Mount Sinai School of Medicine; New York, New York 10029, USA.
Cancer Biology & Therapy
|November 15, 2002
Summary
Protein SUMOylation, a process modifying regulatory proteins, is crucial for cell growth and cancer development. Further research is needed to understand its role in human tumorigenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Small ubiquitin-related modifier (SUMO) proteins are key regulators of cellular processes.
- SUMOylation impacts the function of critical proteins, including oncogenes and tumor suppressors.
- Altered SUMOylation is implicated in tumorigenesis, but evidence in human cancer is limited.
Purpose of the Study:
- To review the current understanding of protein SUMOylation.
- To highlight the significance of SUMOylation in cancer.
- To identify challenges in studying SUMOylation in human cancer.
Main Methods:
- Literature review of existing studies on protein SUMOylation.
- Analysis of the role of SUMOylation in cell growth, differentiation, and apoptosis.
- Examination of the connection between SUMOylation and cancer development.
Main Results:
- SUMOylation modifies substrates' localization, stability, and transcriptional activity.
- Proteins involved in cell growth, differentiation, and apoptosis are SUMOylation targets.
- SUMOylation is hypothesized to play a role in tumorigenesis.
Conclusions:
- Protein SUMOylation is a critical post-translational modification with implications for cancer.
- Further investigation is required to elucidate the precise role and mechanisms of SUMOylation in human cancers.
- Addressing current challenges is essential for advancing cancer research in SUMOylation.
More Related Videos
08:29SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...